Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Exelixis off after proteinuria data

EXEL fell $1.18 (10%) to $10.79 on Tuesday

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE